HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US COVID-19 Fraud: Avenova Eyelid, Eyelash Cleanser Spray Latest Target Of FDA, FTC Warning

Executive Summary

Federal agencies submitted joint warning to NovaBay after reviewing its website and social media pages for its Avenova (hypochlorous acid 0.01%) spray solution.

You may also be interested in...



US COVID-19 Fraud: IV Drip Provider Reconsiders Claims, Bee Honey Joins List Of Unapproved Cures

New York business reconsiders claiming intravenous drips of vitamin blends prevent COVID-19 infections after industry group forwarded concerns to regulators. Latest natural health remedy linked to fraudulent COVID-19 treatment claims is honey from marketers’ beehives.

50 Years After Pioneering Vaginal Care Branding, Combe Fends Off Similar Competing Trademark

Attorneys for Combe tell HBW Insight that the USPTO appeal board’s decision recognizes the marketplace power of a popular brand like Vagisil. Marke Enterprises' proposed Vagisert trademark for similar product was rejected. 

Industry Self-Regulation Review Of Claims Smells Unfair To US Essential Oils Marketer DoTerra

“We firmly believe NAD misunderstood the law and applied the wrong legal standard” says Kirk Jowers, doTerra’s corporate relations chief. But the firm “has little recourse but to comply.”

Topics

UsernamePublicRestriction

Register

RS150661

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel